Is Omnicell Stock a Good Investment?
Omnicell Investment Advice | OMCL |
- Examine Omnicell's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Omnicell's leadership team and their track record. Good management can help Omnicell navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Technology space and any emerging trends that could impact Omnicell's business and its evolving consumer preferences.
- Compare Omnicell's performance and market position to its competitors. Analyze how Omnicell is positioned in terms of product offerings, innovation, and market share.
- Check if Omnicell pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Omnicell's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Omnicell stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Omnicell is a good investment.
Sell | Buy |
Hold
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Omnicell Stock
Researching Omnicell's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.72. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Omnicell has Price/Earnings To Growth (PEG) ratio of 2.28. The entity recorded a loss per share of 0.39. The firm had not issued any dividends in recent years.
To determine if Omnicell is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Omnicell's research are outlined below:
| Omnicell had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 1.15 B. Net Loss for the year was (20.37 M) with profit before overhead, payroll, taxes, and interest of 596.71 M. | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from zacks.com: Wall Street Analysts Believe Omnicell Could Rally 26.73 percent Heres is How to Trade |
Omnicell Quarterly Liabilities And Stockholders Equity |
|
Omnicell uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Omnicell. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Omnicell's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Omnicell's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Omnicell's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2011-05-02 | 2011-03-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2010-10-27 | 2010-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2010-04-26 | 2010-03-31 | 0.1 | 0.09 | -0.01 | 10 | ||
2010-01-28 | 2009-12-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2006-01-30 | 2005-12-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2005-10-20 | 2005-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2004-04-14 | 2004-03-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2013-05-02 | 2013-03-31 | 0.19 | 0.21 | 0.02 | 10 |
Know Omnicell's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Omnicell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Omnicell backward and forwards among themselves. Omnicell's institutional investor refers to the entity that pools money to purchase Omnicell's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | D. E. Shaw & Co Lp | 2024-09-30 | 940.8 K | Federated Hermes Inc | 2024-09-30 | 849.3 K | Macquarie Group Ltd | 2024-06-30 | 831.3 K | Cadian Capital Management Lp | 2024-09-30 | 800 K | Sumitomo Mitsui Trust Group Inc | 2024-09-30 | 750.5 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-06-30 | 716.5 K | Royal Bank Of Canada | 2024-06-30 | 646.5 K | Charles Schwab Investment Management Inc | 2024-09-30 | 595 K | Exchange Traded Concepts, Llc | 2024-06-30 | 525.6 K | Blackrock Inc | 2024-06-30 | 8.2 M | Vanguard Group Inc | 2024-09-30 | 5.5 M |
Omnicell's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.12 B.Market Cap |
|
Omnicell's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.02) | (0.02) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.01) | (0.01) | |
| Return On Equity | (0.02) | (0.02) |
Determining Omnicell's profitability involves analyzing its financial statements and using various financial metrics to determine if Omnicell is a good buy. For example, gross profit margin measures Omnicell's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Omnicell's profitability and make more informed investment decisions.
Omnicell's Earnings Breakdown by Geography
Evaluate Omnicell's management efficiency
Return On Tangible Assets is expected to rise to -0.02 this year. Return On Capital Employed is expected to rise to -0.02 this year. At this time, Omnicell's Intangible Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 297.7 M this year, although the value of Return On Tangible Assets are projected to rise to (0.02). Omnicell's management efficiency ratios could be used to measure how well Omnicell manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 26.30 | 27.61 | |
| Tangible Book Value Per Share | 3.88 | 2.60 | |
| Enterprise Value Over EBITDA | 30.44 | 22.21 | |
| Price Book Value Ratio | 1.43 | 1.36 | |
| Enterprise Value Multiple | 30.44 | 22.21 | |
| Price Fair Value | 1.43 | 1.36 |
Omnicell showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta 0.815 |
Basic technical analysis of Omnicell Stock
As of the 25th of November, Omnicell holds the Semi Deviation of 2.48, risk adjusted performance of 0.0418, and Coefficient Of Variation of 2294.47. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omnicell, as well as the relationship between them. Please check Omnicell treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Omnicell is priced some-what accurately, providing market reflects its current price of 45.69 per share. Given that Omnicell has jensen alpha of 0.0367, we recommend you to check out Omnicell's recent market performance to make sure the company can sustain itself at a future point.Omnicell's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Omnicell insiders, such as employees or executives, is commonly permitted as long as it does not rely on Omnicell's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Omnicell insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Omnicell's Outstanding Corporate Bonds
Omnicell issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Omnicell uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Omnicell bonds can be classified according to their maturity, which is the date when Omnicell has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ON SEMICONDUCTOR P Corp BondUS682189AQ81 | View | |
| OMNICOM GROUP INC Corp BondUS68217FAA03 | View |
Understand Omnicell's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Omnicell's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0418 | |||
| Market Risk Adjusted Performance | 0.1585 | |||
| Mean Deviation | 2.34 | |||
| Semi Deviation | 2.48 | |||
| Downside Deviation | 2.73 | |||
| Coefficient Of Variation | 2294.47 | |||
| Standard Deviation | 4.74 | |||
| Variance | 22.45 | |||
| Information Ratio | 0.016 | |||
| Jensen Alpha | 0.0367 | |||
| Total Risk Alpha | (0.55) | |||
| Sortino Ratio | 0.0278 | |||
| Treynor Ratio | 0.1485 | |||
| Maximum Drawdown | 40.54 | |||
| Value At Risk | (4.42) | |||
| Potential Upside | 5.36 | |||
| Downside Variance | 7.43 | |||
| Semi Variance | 6.13 | |||
| Expected Short fall | (2.85) | |||
| Skewness | 4.74 | |||
| Kurtosis | 32.53 |
| Risk Adjusted Performance | 0.0418 | |||
| Market Risk Adjusted Performance | 0.1585 | |||
| Mean Deviation | 2.34 | |||
| Semi Deviation | 2.48 | |||
| Downside Deviation | 2.73 | |||
| Coefficient Of Variation | 2294.47 | |||
| Standard Deviation | 4.74 | |||
| Variance | 22.45 | |||
| Information Ratio | 0.016 | |||
| Jensen Alpha | 0.0367 | |||
| Total Risk Alpha | (0.55) | |||
| Sortino Ratio | 0.0278 | |||
| Treynor Ratio | 0.1485 | |||
| Maximum Drawdown | 40.54 | |||
| Value At Risk | (4.42) | |||
| Potential Upside | 5.36 | |||
| Downside Variance | 7.43 | |||
| Semi Variance | 6.13 | |||
| Expected Short fall | (2.85) | |||
| Skewness | 4.74 | |||
| Kurtosis | 32.53 |
Consider Omnicell's intraday indicators
Omnicell intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Omnicell stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Omnicell Corporate Filings
F4 | 19th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F3 | 11th of October 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Omnicell Stock media impact
Far too much social signal, news, headlines, and media speculation about Omnicell that are available to investors today. That information is available publicly through Omnicell media outlets and privately through word of mouth or via Omnicell internal channels. However, regardless of the origin, that massive amount of Omnicell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Omnicell news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Omnicell relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Omnicell's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Omnicell alpha.
Omnicell Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Omnicell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Omnicell Corporate Management
| Joseph Spears | Principal Chief Accounting Officer | Profile | |
| Kathleen Nemeth | Senior Relations | Profile | |
| Vicki MacDevitt | Chief Staff | Profile | |
| Sara Dalmasso | Senior International | Profile | |
| Minoo Mortazavi | Senior Operations | Profile | |
| Corey Manley | Executive Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.558 | Earnings Share (0.39) | Revenue Per Share 23.218 | Quarterly Revenue Growth (0.05) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Omnicell's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.